Eur J Pain. 2021 Dec 27; doi: 10.1002/ejp.1901. Epub 2021 Dec 27.

Perceived risk of opioid use disorder secondary to opioid analgesic medication use by the general population in France.

European journal of pain (London, England)

Justine Lavergne, Marion Debin, Thierry Blanchon, Vittoria Colizza, Lise Dassieu, Laetitia Gimenez, Charly Kengne-Kuetche, Maryse Lapeyre-Mestre, Julie Dupouy

PMID: 34958720 DOI: 10.1002/ejp.1901

Abstract

BACKGROUND: In Europe and France, the use of opioid analgesic drugs has become widespread as an option for pain management. However, their use can lead to nonmedical use and/or opioid use disorder (OUD). This work aimed to assess the perceived risk of OUD secondary to opioid analgesic drugs use by the general population.

METHODS: We conducted a cross-sectional observational study using the GrippeNet web-based cohort, comprising about 10,000 French volunteers from the general population, using a self-administered questionnaire. The main outcome was the perceived risk of OUD secondary to opioid analgesic drugs use, assessed by a 4-item scale and modelled using logistic regression (backward procedure).

RESULTS: Among 5046 French respondents, after adjustment, 65% believed that the use of analgesic drugs could likely or very likely lead to OUD. Factors associated with the perception of a higher risk were being over 50 and having heard about opioids in the media. Previous opioid use and a high level of education decreased the perception of the risk. Among those having used opioids in the past 2 years (N = 1770), 71.1% reported being not at all concerned by this risk. The majority of the sample perceived the risk of OUD but those having already used opioid analgesics drugs expressed no concern about this risk for themselves.

CONCLUSIONS: This finding highlight the need to reinforce warning on the package insert documents, therapeutic education and collaborative care between the prescribing general practitioners and pharmacists to increase awareness of opioid medications users on the risk of OUD.

SIGNIFICANCE: This study found that the risk of OUD secondary to opioid analgesics use is well perceived in the general population, but that those having already used opioid analgesics expressed little concern for themselves. This finding could potentially help to raise awareness of healthcare providers and policy makers on the lack of perceived risk regarding these drugs and the need to inform and identify at-risk patients in primary care.

© 2021 European Pain Federation - EFIC ®.

References

1. Association Française des centres d’Addictovigilance. (2020). Bulletin national d’addictovigilance n°14. https://www.chu-toulouse.fr/IMG/pdf/bulletin_national_d_addictovigilance_no_14_tramadol.pdf - PubMed
2. Busse, J. W., Craigie, S., Juurlink, D. N., Buckley, D. N., Wang, L., Couban, R. J., Agoritsas, T., Akl, E. A., Carrasco-Labra, A., Cooper, L., Cull, C., da Costa, B. R., Frank, J. W., Grant, G., Iorio, A., Persaud, N., Stern, S., Tugwell, P., Vandvik, P. O., & Guyatt, G. H. (2017). Guideline for opioid therapy and chronic noncancer pain. CMAJ, 189, E659-E666. https://doi.org/10.1503/cmaj.170363 - PubMed
3. Chenaf, C., Kaboré, J.-L., Delorme, J., Pereira, B., Mulliez, A., Zenut, M., Delage, N., Ardid, D., Eschalier, A., & Authier, N. (2019). Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality. European Journal of Pain, 23, 124-134. https://doi.org/10.1002/ejp.1291 - PubMed
4. Chung, C., Haller, D. M., Sustersic, M., & Sommer, J. (2019). Patient information leaflets-Favoring the sustainability of messages provided to patients following an emergency consultation. Revue Médicale Suisse, 15, 965-970. - PubMed
5. Dassieu, L., Heino, A., Develay, É., Kaboré, J.-L., Pagé, M. G., Moor, G., Hudspith, M., & Choinière, M. (2021). “They think you’re trying to get the drug”: Qualitative investigation of chronic pain patients’ health care experiences during the opioid overdose epidemic in Canada. Canadian Journal of Pain, 5, 66-80. https://doi.org/10.1080/24740527.2021.1881886 - PubMed
6. Daveluy, A., Micallef, J., Sanchez-Pena, P., Miremont-Salamé, G., Lassalle, R., Lacueille, C., Grelaud, A., Corand, V., Victorri-Vigneau, C., Batisse, A., Le Boisselier, R., Peyrière, H., Frauger, E., Lapeyre-Mestre, M., & Haramburu, F. (2021). Ten-year trend of opioid and nonopioid analgesic use in the French adult population. British Journal of Clinical Pharmacology, 87, 555-564. https://doi.org/10.1111/bcp.14415 - PubMed
7. Debin, M., Turbelin, C., Blanchon, T., Bonmarin, I., Falchi, A., Hanslik, T., Levy-Bruhl, D., Poletto, C., & Colizza, V. (2013). Evaluating the feasibility and participants’ representativeness of an online nationwide surveillance system for influenza in France. PLoS One, 8, e73675. https://doi.org/10.1371/journal.pone.0073675 - PubMed
8. Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC Guideline for prescribing opioids for chronic pain-United States, 2016. JAMA, 315, 1624-1645. https://doi.org/10.1001/jama.2016.1464 - PubMed
9. Gillen, C., Haurand, M., Kobelt, D. J., & Wnendt, S. (2000). Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn-Schmiedeberg's Archives of Pharmacology, 362, 116-121. - PubMed
10. Giraudon, I., Lowitz, K., Dargan, P. I., Wood, D. M., & Dart, R. C. (2013). Prescription opioid abuse in the UK. British Journal of Clinical Pharmacology, 76, 823-824. https://doi.org/10.1111/bcp.12133 - PubMed
11. Guerrisi, C., Turbelin, C., Souty, C., Poletto, C., Blanchon, T., Hanslik, T., Bonmarin, I., Levy-Bruhl, D., & Colizza, V. (2018). The potential value of crowdsourced surveillance systems in supplementing sentinel influenza networks: The case of France. Eurosurveillance, 23, 1700337. https://doi.org/10.2807/1560-7917.ES.2018.23.25.1700337 - PubMed
12. Häuser, W., Buchser, E., Finn, D. P., Dom, G., Fors, E., Heiskanen, T., Jarlbaek, L., Knaggs, R. D., Kosek, E., Krcevski-Škvarč, N., Pakkonen, K., Perrot, S., Trouvin, A., & Morlion, B. (2021). Is Europe also facing an opioid crisis?-A survey of European Pain Federation chapters. European Journal of Pain, 25, 1760-1769. https://doi.org/10.1002/ejp.1786 - PubMed
13. Hedegaard, H., Warner, M., & Miniño, A. M. (2017). Drug overdose deaths in the United States, 1999-2016. NCHS Data Brief, 428, 1-8. - PubMed
14. Helmerhorst, G. T., Teunis, T., Janssen, S. J., & Ring, D. (2017). An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: Is Europe next? The Bone & Joint Journal, 99-B, 856-864. https://doi.org/10.1302/0301-620X.99B7.BJJ-2016-1350.R1 - PubMed
15. Hero, J. O., McMurtry, C., Benson, J., & Blendon, R. (2016). Discussing opioid risks with patients to reduce misuse and abuse: Evidence from 2 surveys. Annals of Family Medicine, 14, 575-577. https://doi.org/10.1370/afm.1994 - PubMed
16. Hider-Mlynarz, K., Cavalié, P., & Maison, P. (2018). Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. British Journal of Clinical Pharmacology, 84, 1324-1334. https://doi.org/10.1111/bcp.13564 - PubMed
17. Higgins, C., Smith, B. H., & Matthews, K. (2018). Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: A systematic review and meta-analysis. British Journal of Anaesthesia, 120, 1335-1344. https://doi.org/10.1016/j.bja.2018.03.009 - PubMed
18. Højsted, J., Nielsen, P. R., Guldstrand, S. K., Frich, L., & Sjøgren, P. (2010). Classification and identification of opioid addiction in chronic pain patients. European Journal of Pain, 14, 1014-1020. https://doi.org/10.1016/j.ejpain.2010.04.006 - PubMed
19. INSEE. (2019). Diplômes-Formation en 2016-France. https://www.insee.fr/fr/statistiques/4175605?geo=France-1 - PubMed
20. INSEE. (2020). Population totale par sexe et âge au 1er janvier 2020, France-Bilan démographique 2019. https://www.insee.fr/fr/statistiques/1892086?sommaire=1912926 - PubMed
21. Kaboré, J.-L., Saïdi, H., Dassieu, L., Choinière, M., & Pagé, M. G. (2020). Predictors of long-term opioid effectiveness in patients with chronic non-cancer pain attending multidisciplinary pain treatment clinics: A Quebec pain registry study. Pain Practice, 20, 588-599. https://doi.org/10.1111/papr.12883 - PubMed
22. Kessels, R. P. C. (2003). Patients’ memory for medical information. Journal of the Royal Society of Medicine, 96, 219-222. - PubMed
23. Korownyk, C., Perry, D., Ton, J., Kolber, M. R., Garrison, S., Thomas, B., Allan, G. M., Bateman, C., de Queiroz, R., Kennedy, D., Lamba, W., Marlinga, J., Mogus, T., Nickonchuk, T., Orrantia, E., Reich, K., Wong, N., Dugré, N., & Lindblad, A. J. (2019). Managing opioid use disorder in primary care: PEER simplified guideline. Canadian Family Physician, 65, 321-330. - PubMed
24. Korownyk, C., Perry, D., Ton, J., Kolber, M. R., Garrison, S., Thomas, B., Allan, G. M., Dugré, N., Finley, C. R., Ting, R., Yang, P. R., Vandermeer, B., & Lindblad, A. J. (2019). Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews. Canadian Family Physician, 65, e194-e206. - PubMed
25. Kovatch, M., Feingold, D., Elkana, O., & Lev-Ran, S. (2017). Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients. International Journal of Methods in Psychiatric Research, 26, e1542. https://doi.org/10.1002/mpr.1542 - PubMed
26. Krčevski Škvarč, N., Morlion, B., Vowles, K. E., Bannister, K., Buchsner, E., Casale, R., Chenot, J.-F., Chumbley, G., Drewes, A. M., Dom, G., Jutila, L., O’Brien, T., Pogatzki-Zahn, E., Rakusa, M., Suarez-Serrano, C., Tölle, T., & Häuser, W. (2021). European clinical practice recommendations on opioids for chronic noncancer pain-Part 2: Special situations. European Journal of Pain, 25, 969-985. https://doi.org/10.1002/ejp.1744 - PubMed
27. Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction, 107, 39-50. https://doi.org/10.1111/j.1360-0443.2011.03601.x - PubMed
28. Masson, E. (2021). Validation of a scale for the misuse of opioid analgesics in primary care. Thérapie, 76, 166-167. - PubMed
29. Ministère des Solidarités et de la Santé. (2017). Agnès Buzyn décide d’inscrire la codéine et d’autres dérivés de l’opium à la liste des médicaments disponibles uniquement sur ordonnance. https://solidarites-sante.gouv.fr/actualites/presse/communiques-de-presse/article/agnesbuzyn-decide-d-inscrire-la-codeine-et-d-autres-derives-de-l-opium-a-la - PubMed
30. Moisset, X., Trouvin, A.-P., Tran, V.-T., Authier, N., Vergne-Salle, P., Piano, V., & Martinez, V. (2016). Use of strong opioids in chronic non-cancer pain in adults. Evidence-based recommendations from the French Society for the Study and Treatment of Pain. Presse Medicale, 45, 447-462. - PubMed
31. Murphy, S. L., Xu, J., Kochanek, K. D., & Arias, E. (2018). Mortality in the United States, 2017. NCHS Data Brief, 427, 1-8. - PubMed
32. Roussin, A., Doazan-d’Ouince, O., Géniaux, H., & Halberer, C. (2015). Evaluation of abuse and dependence in addiction monitoring systems: Tramadol as an example. Therapies, 70, 213-221. https://doi.org/10.2515/therapie/2015014 - PubMed
33. Schubert, I., Ihle, P., & Sabatowski, R. (2013). Increase in opiate prescription in Germany between 2000 and 2010: A study based on insurance data. Deutsches Ärzteblatt International, 110, 45-51. - PubMed
34. Tong, S. T., Hochheimer, C. J., Brooks, E. M., Sabo, R. T., Jiang, V., Day, T., Rozman, J. S., Kashiri, P. L., & Krist, A. H. (2019). Chronic opioid prescribing in primary care: Factors and perspectives. The Annals of Family Medicine, 17, 200-206. https://doi.org/10.1370/afm.2357 - PubMed
35. UAA Center for Behavioral Health Research and Services. (2017). Baseline opioid survey: Access, consumption, consequences, and perceptions among young adults in Alaska. - PubMed
36. Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015). Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain, 156, 569-576. https://doi.org/10.1097/01.j.pain.0000460357.01998.f1 - PubMed
37. World Health Organization. (2006). WHO Expert Committee on Drug Dependence: Thirty-fourth report. World Health Organization. - PubMed
38. Xie, J., Strauss, V. Y., Martinez-Laguna, D., Carbonell-Abella, C., Diez-Perez, A., Nogues, X., Collins, G. S., Khalid, S., Delmestri, A., Turkiewicz, A., Englund, M., Tadrous, M., Reyes, C., & Prieto-Alhambra, D. (2021). Association of Tramadol vs codeine prescription dispensation with mortality and other adverse clinical outcomes. JAMA, 326, 1504-1515. https://doi.org/10.1001/jama.2021.15255 - PubMed

Publication Types

• Journal Article